Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,361 | 132 | 99.3% |
| Education | $15.80 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $525.69 | 28 | $0 (2022) |
| PFIZER INC. | $290.82 | 27 | $0 (2021) |
| Biocompatibles, Inc. | $237.09 | 6 | $0 (2019) |
| Amgen Inc. | $203.95 | 13 | $0 (2021) |
| Allergan, Inc. | $183.53 | 9 | $0 (2022) |
| Tactile Systems Technology Inc | $100.29 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $96.18 | 5 | $0 (2018) |
| Bard Peripheral Vascular, Inc. | $94.36 | 3 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $82.95 | 5 | $0 (2018) |
| Medtronic Vascular, Inc. | $73.50 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.89 | 1 | Tactile Systems Technology Inc ($18.89) |
| 2022 | $472.32 | 13 | Allergan, Inc. ($157.91) |
| 2021 | $437.21 | 26 | Janssen Pharmaceuticals, Inc ($181.15) |
| 2020 | $263.35 | 16 | Amgen Inc. ($70.87) |
| 2019 | $239.40 | 21 | PFIZER INC. ($120.75) |
| 2018 | $438.95 | 20 | Biocompatibles, Inc. ($204.75) |
| 2017 | $506.39 | 37 | Janssen Pharmaceuticals, Inc ($69.73) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/13/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 10/25/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2022 | Tactile Systems Technology Inc | Flexitouch Plus (Device), entre | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 07/26/2022 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $27.86 | General |
| Category: WOUND CARE | ||||||
| 06/26/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $27.02 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/26/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $24.66 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/26/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $13.57 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/25/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $36.70 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/25/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $25.58 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/25/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $23.30 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/25/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $7.08 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/15/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $112.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/28/2022 | Tactile Systems Technology Inc | Flexitouch Plus (Device), entre | Food and Beverage | In-kind items and services | $60.64 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 04/27/2022 | Bard Peripheral Vascular, Inc. | Venclose Maven Catheter (Device) | Food and Beverage | In-kind items and services | $73.00 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 12/09/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/18/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/26/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/19/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/30/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/27/2021 | Bard Peripheral Vascular, Inc. | — | Food and Beverage | In-kind items and services | $17.31 | General |
| 09/27/2021 | Bard Peripheral Vascular, Inc. | — | Food and Beverage | In-kind items and services | $4.05 | General |
| 09/17/2021 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: ET | ||||||
| 08/25/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/10/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Cardiology | ||||||
| 07/28/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 838 | 1,182 | $1.6M | $274,072 |
| 2022 | 12 | 748 | 973 | $1.2M | $205,096 |
| 2021 | 17 | 967 | 1,398 | $1.1M | $236,694 |
| 2020 | 17 | 878 | 1,330 | $833,845 | $172,701 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2023 | 77 | 168 | $932,550 | $145,063 | 15.6% |
| 36471 | Injection of chemical agent into multiple incompetent veins of leg | Office | 2023 | 101 | 216 | $146,880 | $32,155 | 21.9% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 176 | 184 | $118,680 | $26,679 | 22.5% |
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2023 | 12 | 13 | $96,868 | $14,415 | 14.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 95 | 95 | $47,990 | $12,153 | 25.3% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 96 | 191 | $107,688 | $9,220 | 8.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 84 | $28,005 | $7,960 | 28.4% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 68 | 80 | $30,588 | $7,246 | 23.7% |
| 37766 | Removal of varicose veins of arm or leg, more than 20 incisions | Office | 2023 | 20 | 25 | $70,200 | $6,745 | 9.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 83 | $17,885 | $5,685 | 31.8% |
| 36476 | Destruction of subsequent incompetent veins of arm or leg using radiofrequency and imaging guidance | Office | 2023 | 18 | 24 | $25,880 | $5,360 | 20.7% |
| 10160 | Aspiration of abscess, blood, or cyst | Office | 2023 | 15 | 19 | $7,040 | $1,391 | 19.8% |
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2022 | 64 | 113 | $669,450 | $103,953 | 15.5% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2022 | 169 | 175 | $113,148 | $26,146 | 23.1% |
| 36471 | Injection of chemical agent into multiple incompetent veins of leg | Office | 2022 | 69 | 143 | $98,330 | $21,716 | 22.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 91 | $28,311 | $9,050 | 32.0% |
| 37766 | Removal of varicose veins of arm or leg, more than 20 incisions | Office | 2022 | 21 | 27 | $78,200 | $8,344 | 10.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 65 | 65 | $25,930 | $8,173 | 31.5% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2022 | 67 | 72 | $30,264 | $6,808 | 22.5% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 66 | 130 | $71,709 | $6,384 | 8.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 63 | 63 | $25,545 | $5,621 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 66 | $14,065 | $4,891 | 34.8% |
| 36476 | Destruction of subsequent incompetent veins of arm or leg using radiofrequency and imaging guidance | Office | 2022 | 11 | 13 | $10,628 | $3,003 | 28.3% |
| 10160 | Aspiration of abscess, blood, or cyst | Office | 2022 | 13 | 15 | $4,548 | $1,008 | 22.2% |
| 36475 | Destruction of insufficient vein of arm or leg, accessed through the skin | Office | 2021 | 57 | 119 | $601,990 | $119,133 | 19.8% |
About Dr. David Smith, M.D
Dr. David Smith, M.D is a Cardiovascular Disease healthcare provider based in Painesville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316980246.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Smith, M.D has received a total of $2,377 in payments from pharmaceutical and medical device companies, with $18.89 received in 2024. These payments were reported across 134 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,361).
As a Medicare-enrolled provider, Smith has provided services to 3,431 Medicare beneficiaries, totaling 4,883 services with total Medicare billing of $888,562. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Painesville, OH
- Active Since 06/14/2006
- Last Updated 02/16/2015
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1316980246
Products in Payments
- XARELTO (Drug) $525.69
- VARITHENA (Drug) $237.09
- ELIQUIS (Drug) $172.83
- BOTOX (Biological) $157.91
- Corlanor (Drug) $155.15
- Flexitouch Plus (Device) $100.29
- PRALUENT ALIROCUMAB INJECTION (Biological) $96.18
- PRALUENT (Drug) $82.95
- VYNDAQEL (Drug) $80.59
- Venclose Maven Catheter (Device) $73.00
- CHANTIX (Drug) $70.43
- ENTRESTO (Drug) $64.33
- ClosureFast (Device) $59.31
- BRILINTA (Drug) $49.82
- Repatha (Biological) $48.80
- JARDIANCE (Drug) $42.46
- Puraply (Medical Supply) $27.86
- Vascepa (Drug) $24.62
- PRADAXA (Drug) $20.57
- UBRELVY (Drug) $19.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.